IL22 and Crohn disease: This shift has been proposed as a contributor to the observed changes between non-inflamed tissue versus inflamed regions of patients with Crohn’s disease where there is a substantial increase in IFNγ-producing CD127+ ILC1s at the cost of homeostatic IL-22 producing NKp44+ ILC3s in the inflamed intestine (61).